AstraZeneca and Oxford University (UK) have resumed the progress of their Phase III COVID-19 vaccine trial after investigating unexpected side effects in a patient enrolled in the trial in the UK.
In an exclusive interview with an author behind one of the papers published in the recent Future Virology Special Focus Issue, heptatitis and COVID-19 are discussed.
By investigating the lung microbiome we can increase our understanding and therefore treatment avenues for CF lung infections.
In this Commentary article published in the Special Focus Issue in Future Virology on the COVID-19 pandemic, researchers study the safety of different populations in regard to the spread of disease.
COVID-19 patients who develop a cytokine storm in response to infection could be unable to produce memory cells that provide long-term protection against SARS-CoV-2.
In this Special Report from the ‘COVID-19: studying the global pandemic’ Special Focus Issue authors theorize about the identification of asymptomatic patients and the impact this has on the spread of COVID-19.
An epidemiological study has revealed that COVID-19 outcomes are better in those countries that have undertaken a TB vaccination regime in the last 15 years.
In this interview with Alessandra Renieri we hear about the GEN-COVID network in Italy working to dsicover the genetic variability in COVID-19 patients who show phenotypic differences and what this means for treating the disease.
A study undertaken in South Korea has shown that the viral load in asymptomatic COVID-19 patients is the same as in those who show symptoms of the disease and this could be contributing to the spread of the infection in populations.
Malara parasites showing artemisinin resistance previously seen in South-East Asia have recently emerged in areas of Rwanda in Sub-Saharan Africa. If the mutation causing resistance becomes prevalent across the continent it could have major public health impacts.